Editorial Commentary: Addressing Disparities in HIV Mortality: Antiretroviral Therapy Is Necessary but Not Sufficient

Smith, Kimberly Y.
June 2013
Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 12, p1810
Academic Journal
An introduction is presented in which the editor discusses the study which examines the influence of geographic origin and race/ethnicity on HIV mortality in patients on antiretroviral therapy (ART) in Canada, Europe, and the U.S.


Related Articles

  • HIV-positive people on ART have the same mortality risk to HIV-negative people.  // HIV Australia;2013, Vol. 11 Issue 2, p5 

    The article presents information on a report according to which HIV-positive persons responding well to antiretroviral therapy have no higher mortality risk as compared to their HIV-negative peers.

  • Incidence of Tuberculosis during Highly Active Antiretroviral Therapy in High-Income and Low-Income Countries. Lawn, Stephen D.; Wood, Robin // Clinical Infectious Diseases;12/15/2005, Vol. 41 Issue 12, p1783 

    The article presents the author's comments on the incidence of Tuberculosis during highly active antiretroviral therapy in high-income and low-income countries. Highly active antiretroviral therapy (HAART) has revolutionized the care of HIV-infected individuals, causing major reductions in...

  • Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study. Panos, George; Samonis, George; Alexiou, Vangelis G.; Kavarnou, Garyfallia A.; Charatsis, Gerasimos; Falagas, Matthew E. // Current HIV Research;May2008, Vol. 6 Issue 3, p257 

    HAART has substantially decreased mortality and morbidity among HIV-infected patients. We retrospectively analyzed morbidity and mortality in a cohort of HIV-infected adult patients with prolonged and frequent follow up (1987-2006). The study was divided in pre-HAART and HAART period for...

  • Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study.  // AIDS Research & Therapy;2012, Vol. 9, p15 

    The article offers information regarding a study which aimed to examine mortality and its predictors among a cohort of HIV infected patients on anti-retroviral treatment retrospectively followed for five years in Ethiopia. As reported, a total of 1540 study participants were included. As stated,...

  • Mortality among HIV-Infected Patients in Resource Limited Settings: A Case Controlled Analysis of Inpatient's at a Community Care Center. Rajagopalan, Nirmala; Suchitra, Joyce B.; Shet, Anita; Khan, Zafar K.; Martin-Garcia, Julio; Nonnemacher, Michael R.; Jacobson, Jeffrey M.; Wigdahl, Brian // American Journal of Infectious Diseases;2009, Vol. 5 Issue 3, p219 

    Problem statement: Despite massive national efforts to scale up Antiretroviral Therapy (ART) access in India since 2004, the AIDS death rate was 17.2 per 100,000 persons during 2003- 2005. In the era of HAART in resource poor settings, it is imperative to understand and address the causes of...

  • Sensitivity of chronically HIV-1 infected HeLa cells to electrical stimulation. Kumagai, E.; Tominaga, M.; Harada, S. // Applied Microbiology & Biotechnology;Feb2004, Vol. 63 Issue 6, p754 

    Use of combination anti-retroviral drug regimens including protease inhibitors dramatically decreased morbidity and mortality rates in HIV-1 infected individuals. However, such combination therapies appear to have many side effects, in addition to the emergence of resistant HIV-1 strains....

  • Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act. Robert W. Burgoyne; Darrell H. S. Tan // Journal of Antimicrobial Chemotherapy (JAC);Mar2008, Vol. 61 Issue 3, p469 

    Advances in highly active antiretroviral therapy (HAART) options for people living with HIV/AIDS have resulted in decreased morbidity and mortality. To some extent, the role of disease progression in eroding quality of life (QOL) erosion in the pre-HAART age is now supplanted by drug toxicities,...

  • Despite early ART, mortality high in adults with HIV, TB.  // Infectious Disease News;Jun2014, Vol. 27 Issue 6, p40 

    The article reports on the Cambodian Early versus Late Introduction of Antiretrovirals (CAMELIA) trial which found high mortality among adults with tuberculosis and HIV despite early introduction of antiretroviral theraphy.

  • Free antiretroviral treatment effective in Malawi.  // Infectious Disease News;Jun2008, Vol. 21 Issue 6, p39 

    The article reports on the results of a study on the efficiency of antiretroviral therapy in Malawi. It revealed that mortality rates of patients with HIV and AIDS have been reduced following the introduction of free antiretroviral therapy. According to researchers, the mortality rate was 9.8...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics